Related Experiment Videos
Hypothesis for the pathogenesis of type 1A diabetes
Jean M Jasinski1, George S Eisenbarth
1Human Medical Genetics Program, University of Colorado Health Sciences Center, Denver, Colorado, USA.
Drugs of Today (Barcelona, Spain : 1998)
|April 12, 2005
Summary
Type 1A diabetes involves T-cell destruction of insulin-producing beta cells. Genetic factors, like human leukocyte antigen (HLA) genes, play a key role, and predicting and preventing this autoimmune condition is now possible.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Type 1A diabetes is an autoimmune disease caused by T-cell mediated destruction of pancreatic islet beta cells.
- Disease development progresses through stages, from genetic susceptibility to complete beta cell loss.
- The major histocompatibility complex (MHC), specifically human leukocyte antigen (HLA) DR and DQ genes, is a primary genetic susceptibility locus.
Purpose of the Study:
- To elucidate the pathogenesis of Type 1A diabetes.
- To highlight the genetic and environmental factors contributing to autoimmune diabetes.
- To discuss the current state of predicting and preventing Type 1A diabetes.
Main Methods:
- Review of existing literature on Type 1A diabetes pathogenesis.
- Analysis of genetic susceptibility loci, including MHC/HLA region.
- Examination of rare single-gene disorders and multifactorial forms of autoimmune diabetes.
Main Results:
- T-cell mediated beta cell destruction is the hallmark of Type 1A diabetes.
- Genetic predisposition, particularly HLA variants, significantly influences disease risk.
- Both polygenic inheritance and unidentified environmental factors contribute to common forms of Type 1A diabetes.
Conclusions:
- Understanding the stages of Type 1A diabetes development is crucial.
- Predictive capabilities for Type 1A diabetes are improving.
- Preventive therapies for Type 1A diabetes are an active area of research.